Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $13.86 USD
Change Today -0.28 / -1.98%
Volume 360.3K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael G. Kauffman M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director,Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael G. Kauffman, M.D., Ph.D., co-founded Karyopharm Therapeutics, Inc. in 2008 and has been its Chief Executive Officer since January 5, 2011, Dr. Kauffman served as President at Karyopharm Therapeutics, Inc. from January 2011 to December 2013 and Chief Medical Officer since December 2012 until December 2013. Dr. Kauffman serves as President of OutlineMed Inc. He served as the Consultant of Onyx Pharmaceuticals, Inc. since December 31, 2010. He served as Clinical ...

Read Full Background

Corporate Headquarters*

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships*

Co-Founder, Chief Executive Officer and Director
Independent Director, Member of Compensation Committee and Member of Audit Committee


Post-Doctoral Training
Harvard University
Johns Hopkins University
Johns Hopkins University
Amherst College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$440,000

Stock Options*

All Other Compensation$10,820
Exercisable Options237,745
Exercisable Options Value$7,344,060
Unexercisable Options458,315
Unexercisable Options Value$13,095,930
Total Value of Options$20,439,989
Total Number of Options696,060

Total Compensation*

Total Annual Cash Compensation$648,820
Total Short Term Compensation$440,000
Other Long Term Compensation$10,820
Total Calculated Compensation$648,820
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPTI:US $13.86 USD -0.28


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARYOPHARM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at